Literature DB >> 18303108

Survival and cause of death in multiple sclerosis: a prospective population-based study.

C Hirst1, R Swingler, D A S Compston, Y Ben-Shlomo, N P Robertson.   

Abstract

BACKGROUND: Detailed studies of mortality in multiple sclerosis (MS) are limited. Studying death certificates in a prospective cohort of patients known to have MS is of value in establishing mortality data and can also provide important information on the accuracy and use of death certificates for epidemiological studies.
METHODS: A population-based survey performed in South Wales in 1985 identified 441 patients. Cases were flagged with the Office of Population Censuses and Surveys and death certificates collected prospectively for more than 20 years.
RESULTS: Median observed survival time was 38.0 years from symptom onset. Mean age at death was 65.3 for women and 65.2 years for men. Mean age at death in patients dying from MS-related causes was 62.5 and 69.3 years (p<0.001) for unrelated deaths. Those dying of MS-related causes had a younger age at disease onset (32.5) compared with those dying of unrelated causes (36.8 years) (p = 0.01). Cause of death was related to MS in 57.9% and unrelated in 42.1% of individuals. In 27% of patients, "MS" was absent from the death certificate. The most common cause of death was respiratory disease (47.5%). The standardised mortality ratio was 2.79 (95% CI 2.44 to 3.18) so that MS patients were almost three times more likely to die prematurely relative to the general population.
CONCLUSIONS: These results confirm a continuing trend of premature death in patients with MS. Relying on data derived from death certificates will underestimate disease prevalence. Differences were identified between those dying from MS-related causes and those dying from other causes.

Entities:  

Mesh:

Year:  2008        PMID: 18303108     DOI: 10.1136/jnnp.2007.127332

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  32 in total

Review 1.  Effects of the Menstrual Cycle on Neurological Disorders.

Authors:  Hannah J Roeder; Enrique C Leira
Journal:  Curr Neurol Neurosci Rep       Date:  2021-05-10       Impact factor: 5.081

Review 2.  [Choice of early and escalation treatment options for multiple sclerosis].

Authors:  R A Linker; B C Kieseier
Journal:  Nervenarzt       Date:  2008-10       Impact factor: 1.214

3.  Physical activity and self-reported cardiovascular comorbidities in persons with multiple sclerosis: evidence from a cross-sectional analysis.

Authors:  Robert W Motl; Bo Fernhall; Edward McAuley; Gary Cutter
Journal:  Neuroepidemiology       Date:  2011-05-20       Impact factor: 3.282

Review 4.  Wellness and the Role of Comorbidities in Multiple Sclerosis.

Authors:  Brandon P Moss; Mary R Rensel; Carrie M Hersh
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

5.  Multiple cause of death analysis in multiple sclerosis: A population-based study.

Authors:  Katharine Harding; Feng Zhu; Mohammed Alotaibi; Thomas Duggan; Helen Tremlett; Elaine Kingwell
Journal:  Neurology       Date:  2020-01-13       Impact factor: 9.910

6.  Ventilatory impairment in the dysmyelinated Long Evans shaker rat.

Authors:  R A Johnson; T L Baker-Herman; I D Duncan; G S Mitchell
Journal:  Neuroscience       Date:  2010-06-11       Impact factor: 3.590

Review 7.  Mortality in patients with multiple sclerosis.

Authors:  Antonio Scalfari; Volker Knappertz; Gary Cutter; Douglas S Goodin; Raymond Ashton; George C Ebers
Journal:  Neurology       Date:  2013-07-09       Impact factor: 9.910

8.  Cervical spinal demyelination with ethidium bromide impairs respiratory (phrenic) activity and forelimb motor behavior in rats.

Authors:  N L Nichols; A M Punzo; I D Duncan; G S Mitchell; R A Johnson
Journal:  Neuroscience       Date:  2012-11-14       Impact factor: 3.590

Review 9.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases.

Authors:  Glinda S Cooper; Milele L K Bynum; Emily C Somers
Journal:  J Autoimmun       Date:  2009-10-09       Impact factor: 7.094

10.  Predictors of Mortality in Veterans with Multiple Sclerosis in an Outpatient Clinic Setting.

Authors:  Meheroz H Rabadi; Christopher E Aston
Journal:  Int J MS Care       Date:  2017 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.